# EDGAR Filing Document

**Accession Number:** 0001434316
**File Stem:** 0001273087-23-000102
**Filing Date:** 2023-3
**Character Count:** 15140
**Document Hash:** e4f318f0e653d63ffa06a52211675664
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001273087-23-000102.hdr.sgml**: 20230322

**ACCESSION NUMBER**: 0001273087-23-000102

**CONFORMED SUBMISSION TYPE**: SC 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230322

**DATE AS OF CHANGE**: 20230322

**GROUP MEMBERS**: ISRAEL A. ENGLANDER

**GROUP MEMBERS**: MILLENNIUM GROUP MANAGEMENT LLC

**GROUP MEMBERS**: MILLENNIUM MANAGEMENT LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FATE THERAPEUTICS INC
- **CENTRAL INDEX KEY:** 0001434316
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 651311552
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-87649
- **FILM NUMBER:** 23753103

**BUSINESS ADDRESS:**
- **STREET 1:** 12278 SCRIPPS SUMMIT DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92131
- **BUSINESS PHONE:** 858.875.1803

**MAIL ADDRESS:**
- **STREET 1:** 12278 SCRIPPS SUMMIT DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92131
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MILLENNIUM MANAGEMENT LLC
- **CENTRAL INDEX KEY:** 0001273087
- **IRS NUMBER:** 133804139
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 399 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** (212) 841-4100

**MAIL ADDRESS:**
- **STREET 1:** 399 PARK AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MILLENNIUM MANAGEMENT, L.L.C.
- **DATE OF NAME CHANGE:** 20050310

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MILLENNIUM MANAGEMENT LLC
- **DATE OF NAME CHANGE:** 20031212

**UNITED STATES <br>SECURITIES AND EXCHANGE COMMISSION<br>Washington, D.C. 20549<br>SCHEDULE 13G<br>Under the Securities Exchange Act of 1934<br>

---

| |
|:---|
| **FATE THERAPEUTICS, INC.** |
| (Name of Issuer) |

---

---

| |
|:---|
| **COMMON STOCK, PAR VALUE $0.001 PER SHARE** |
| (Title of Class of Securities) |

---

---

| |
|:---|
| **31189P102**  |
| (CUSIP Number) |

---

---

| |
|:---|
| **MARCH 16, 2023** |
| (Date of event which requires filing of this statement) |

---

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

□ Rule 13d-1(b)

🗹 Rule 13d-1(c)

□ Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).** 

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>2</sub> | of<sub>10</sub> |

---

---

| | |
|:---|:---|
| **1** | NAMES OF REPORTING PERSONS<br>Millennium Management LLC |
| **2** | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) □ <br> (b) □<br>|
| **3** | SEC USE ONLY |
| **4** | CITIZENSHIP OR PLACE OF ORGANIZATION<br>Delaware |

---

---

| | | |
|:---|:---|:---|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **5** | SOLE VOTING POWER<br>-0- |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **6** | SHARED VOTING POWER<br>1,696,431 (See Item 4(a))  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **7** | SOLE DISPOSITIVE POWER<br>-0-  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **8** | SHARED DISPOSITIVE POWER<br>1,696,431 (See Item 4(a))  |

---

---

| | |
|:---|:---|
| **9** | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>1,696,431 (See Item 4(a))  |
| **10** | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>□ |
| **11** | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>1.7%  |
| **12** | TYPE OF REPORTING PERSON<br>OO |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>3</sub> | of<sub>10</sub> |

---

---

| | |
|:---|:---|
| **1** | NAMES OF REPORTING PERSONS<br>Millennium Group Management LLC |
| **2** | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) □ <br> (b) □<br>|
| **3** | SEC USE ONLY |
| **4** | CITIZENSHIP OR PLACE OF ORGANIZATION<br>Delaware |

---

---

| | | |
|:---|:---|:---|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **5** | SOLE VOTING POWER<br>-0- |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **6** | SHARED VOTING POWER<br>1,696,431 (See Item 4(a))  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **7** | SOLE DISPOSITIVE POWER<br>-0-  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **8** | SHARED DISPOSITIVE POWER<br>1,696,431 (See Item 4(a))  |

---

---

| | |
|:---|:---|
| **9** | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>1,696,431 (See Item 4(a))  |
| **10** | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>□ |
| **11** | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>1.7%  |
| **12** | TYPE OF REPORTING PERSON<br>OO |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>4</sub> | of<sub>10</sub> |

---

---

| | |
|:---|:---|
| **1** | NAMES OF REPORTING PERSONS<br>Israel A. Englander |
| **2** | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) □ <br> (b) □<br>|
| **3** | SEC USE ONLY |
| **4** | CITIZENSHIP OR PLACE OF ORGANIZATION<br>United States |

---

---

| | | |
|:---|:---|:---|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **5** | SOLE VOTING POWER<br>-0- |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **6** | SHARED VOTING POWER<br>1,696,431 (See Item 4(a))  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **7** | SOLE DISPOSITIVE POWER<br>-0-  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH | **8** | SHARED DISPOSITIVE POWER<br>1,696,431 (See Item 4(a))  |

---

---

| | |
|:---|:---|
| **9** | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>1,696,431 (See Item 4(a)) |
| **10** | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES<br>□  |
| **11** | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>1.7% |
| **12** | TYPE OF REPORTING PERSON<br>IN |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>5</sub> | of<sub>10</sub> |

---

---

| | |
|:---|:---|
| <u>Item 1.</u> |  |
| (a) | <u>Name of Issuer</u>: |
|  | Fate Therapeutics, Inc. |
| (b) | <u>Address of Issuer's Principal Executive Offices</u>: |
|  | 12278 Scripps Summit Drive<br>San Diego, California 92131 <br>|
| <u>Item 2.</u><br> (a) | <u>Name of Person Filing</u>: |
| (b) | <u>Address of Principal Business Office</u>: |
| (c) | <u>Citizenship</u>: |
|  | Millennium Management LLC<br>399 Park Avenue<br>New York, New York 10022<br>Citizenship: Delaware |
|  | Millennium Group Management LLC <br>399 Park Avenue <br>New York, New York 10022 <br>Citizenship: Delaware |
|  | Israel A. Englander <br>c/o Millennium Management LLC<br>399 Park Avenue<br>New York, New York 10022<br>Citizenship: United States |
| (d) | <u>Title of Class of Securities</u>: |
|  | common stock, par value $0.001 per share ("Common Stock") |
| (e) | <u>CUSIP Number:</u> |
|  | 31189P102 |

---

<u>Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:</u>

&nbsp;&nbsp;&nbsp;&nbsp;(a) □ Broker or dealer
 registered under section 15 of the Act (15 U.S.C. 78o);

&nbsp;&nbsp;&nbsp;&nbsp;(b) □ Bank as defined in
 section 3(a)(6) of the Act (15 U.S.C. 78c);

&nbsp;&nbsp;&nbsp;&nbsp;(c) □ Insurance company as
 defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

&nbsp;&nbsp;&nbsp;&nbsp;(d) □ Investment company
 registered under section 8 of the Investment Company Act of 1940 (15
 U.S.C. 80a-8);

&nbsp;&nbsp;&nbsp;&nbsp;(e) □ An investment adviser
 in accordance with
§240.13d-1(b)(1)(ii)(E);

&nbsp;&nbsp;&nbsp;&nbsp;(f) □ An employee benefit
 plan or endowment fund in accordance with
 §240.13d-1(b)(1)(ii)(F);

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>6</sub> | of<sub>10</sub> |

---

&nbsp;&nbsp;&nbsp;&nbsp;(g) □ A parent holding
 company or control person in accordance with
 §240.13d-1(b)(1)(ii)(G);

&nbsp;&nbsp;&nbsp;&nbsp;(h) □ A savings association
 as defined in Section 3(b) of the Federal Deposit Insurance Act (12
 U.S.C. 1813);

&nbsp;&nbsp;&nbsp;&nbsp;(i) □ A church plan that is
 excluded from the definition of an investment company under section
 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.
 80a-3);

&nbsp;&nbsp;&nbsp;&nbsp;(j) □ Group, in accordance
 with §240.13d-1(b)(1)(ii)(J).

<u>Item 4. Ownership</u>

&nbsp;&nbsp;&nbsp;&nbsp;Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

<u>(a) Amount Beneficially Owned:</u> 

&nbsp;&nbsp;&nbsp;&nbsp;See response to Item 9 on each cover page.

&nbsp;&nbsp;&nbsp;&nbsp;After acquiring beneficial ownership of more than 5% of the outstanding Common Stock on March 16, 2023, the reporting persons ceased to be beneficial owners of more than 5% of the outstanding Common Stock by the date of this filing.

<u>(b) Percent of Class:</u>

&nbsp;&nbsp;&nbsp;&nbsp;See response to Item 11 on each cover page.

 <u>(c) Number of shares as to which such person has:</u> (i) Sole power to vote or to direct the vote

&nbsp;&nbsp;&nbsp;&nbsp;See response to Item 5 on each cover page.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>7</sub> | of<sub>10</sub> |

---

(ii) Shared power to vote or to direct the vote

&nbsp;&nbsp;&nbsp;&nbsp;See response to Item 6 on each cover page.

(iii) Sole power to dispose or to direct the disposition of

&nbsp;&nbsp;&nbsp;&nbsp;See response to Item 7 on each cover page.

(iv) Shared power to dispose or to direct the disposition of

&nbsp;&nbsp;&nbsp;&nbsp;See response to Item 8 on each cover page.

&nbsp;&nbsp;&nbsp;&nbsp;The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

<u>Item 5. Ownership of Five Percent or Less of a Class</u> 

&nbsp;&nbsp;&nbsp;&nbsp;If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following 🗹.

<u>Item 6. Ownership of More than Five Percent on Behalf of Another Person.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.

<u>Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.

<u>Item 8. Identification and Classification of Members of the Group</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See Exhibit I.

<u>Item 9. Notice of Dissolution of Group</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.

<u>Item 10. Certification</u> 

&nbsp;&nbsp;&nbsp;&nbsp;By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>8</sub> | of<sub>10</sub> |

---

Exhibits:

Exhibit I: Joint Filing Agreement, dated as of March 21, 2023, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>9</sub> | of<sub>10</sub> |
|  |  | **SIGNATURE** |  |  |

---

**

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.<br>Dated: March 21, 2023

---

| |
|:---|
| &nbsp;&nbsp; MILLENNIUM MANAGEMENT LLC |
| &nbsp;&nbsp; MILLENNIUM GROUP MANAGEMENT LLC |
| &nbsp;&nbsp;/s/ Israel A. Englander  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| CUSIP No. | 31189P102  | **SCHEDULE 13G** | Page<sub>10</sub> | of<sub>10</sub> |
|  |  | **EXHIBIT I** |  |  |
|  |  | **JOINT FILING AGREEMENT** |  |  |

---

This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Fate Therapeutics, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.<br>Dated: March 21, 2023

---

| |
|:---|
| &nbsp;&nbsp; MILLENNIUM MANAGEMENT LLC |
| &nbsp;&nbsp;By: /s/Gil Raviv |
| &nbsp;&nbsp; MILLENNIUM GROUP MANAGEMENT LLC |
| &nbsp;&nbsp;By: /s/Gil Raviv |
| &nbsp;&nbsp;/s/ Israel A. Englander  |

---